Hong Kong-based Zuellig Pharma buys Singapore healthcare startup Klinify

Klinify is being used by 800 doctors in Malaysia to manage their clinics.

Zuellig Pharma has acquired Singapore-based Healthtech startup Klinify, which is said to support the technology development that helps doctors modernise their practices and simplify workflows, an announcement revealed.

Klinify is a cloud-based digital medical assistant used by over 800 doctors in Malaysia to manage their clinics more efficiently.

“The ability to integrate with [Zuellig Pharma’s] existing services allows doctors to get significantly more value out of Klinify as it will create a single portal for many of their clinic management needs,” said Krish Surendran, founder and CEO of Klinify.

In 2017, Klinify bagged an undisclosed investment from the pharma firm, where they planned to utilise its proceeds for its regional expansion and product development.